Banking Recap

M&A Transaction Announced for $340.0M

Edgewell Personal Care Company announced on November 12, 2025 that it had entered into a definitive agreement to sell its feminine care business, which includes the Playtex, Stayfree, Carefree and o.b. brands, to Essity, a Swedish global health and hygiene company, for $340 million. CEO Rod Little characterized the sale as "a pivotal step in Edgewell's transformation," sharpening the company's focus on its core shaving, sun and skin care, and personal care categories.

Nov 13, 2025·SEC EDGAR (8-K)·pending regulatory·divestiture (business sale)

Deal value

This record is sourced from an Exhibit 99.1 press release furnished with Edgewell's Form 8-K filed November 13, 2025 (dated November 12, 2025). At announcement, the transaction was a signed definitive agreement pending customary closing conditions and regulatory approvals, with closing expected in the first quarter of calendar 2026.

Perella Weinberg Partners LP served as sole financial advisor to Edgewell on the sale, per the release's statement "Perella Weinberg Partners LP is serving as financial advisor to Edgewell. Latham & Watkins LLP is serving as legal advisor to Edgewell." No financial advisor to Essity is named in this release, and no lead designation applies since Perella Weinberg was Edgewell's only disclosed financial advisor.

On the legal side, Latham & Watkins LLP represented Edgewell; no legal advisor for Essity is disclosed in this release.

Edgewell disclosed it intends to use net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet while continuing to invest in core-business growth, and that it will provide Essity with transition services to support the business's handover; beginning in the first quarter of fiscal 2026, Edgewell will classify Feminine Care as discontinued operations. The company estimated the divestiture's annualized impact at approximately $0.40 to $0.50 in adjusted EPS and $35 million to $45 million in adjusted EBITDA, net of transition-service income.

Not disclosed in the sourced document is any enterprise-value-to-EBITDA multiple implied by the $340 million price, Essity's financial advisor (if any), or the precise split of the sale price between cash and other consideration beyond the stated $340 million aggregate figure.